Product Information
VENLAFAXINE HCL 50 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0894 per EA under NDC 62332001031. Its NADAC has been published 552 times since Mar 9, 2016.
FDA first approved this application on Dec 14, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001031
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078932FDA Approved
12/14/2010
TE Code
AB
On Market Since
10/1/2015
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 50 MG TABLET has been published 552 times since Mar 9, 2016, and over the history we have for it it has declined 71.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0894 per EA |
|---|---|
| All-time high | $0.3839 (Dec 14, 2016) |
| All-time low | $0.0537 (Jan 18, 2023) |
| 52-week high | $0.1047 |
| 52-week low | $0.0797 |
| Median price | $0.1630 |
| Average price | $0.1705 |
| Largest weekly change | +66.0% (Jun 19, 2024) |
| Weeks tracked | 552 |
| Tracking since | Mar 9, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the venlafaxine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
venlafaxine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 50 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0894 per EA (NDC 62332001031), effective Sep 30, 2026.
How has the price of VENLAFAXINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 50 MG TABLET has declined 71.5%. It has been tracked across 552 weekly CMS publications since Mar 9, 2016.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 50 MG TABLET?
Since Mar 9, 2016, the NADAC for VENLAFAXINE HCL 50 MG TABLET has ranged from a low of $0.0537 (Jan 18, 2023) to a high of $0.3839 (Dec 14, 2016), with a median of $0.1630 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VENLAFAXINE HCL 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VENLAFAXINE HCL 50 MG TABLET?
VENLAFAXINE HCL 50 MG TABLET (NDC 62332001031) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.